Profound Medical CFO Transition
Analysis based on 8 articles · First reported Aug 14, 2026 · Last updated Aug 14, 2026
The CFO transition is a routine management change with limited direct market impact. Investors may view the appointment of an internal interim CFO as a sign of continuity, but the departure of the previous CFO could introduce some uncertainty.
Profound Medical Corp., a commercial-stage medical device company, announced the promotion of Matthew Sobczyk from Corporate Controller to Interim Chief Financial Officer, effective immediately. Sobczyk succeeds Rashed Dewan, who has stepped down as CFO but will remain on a short-term consulting contract to ensure a smooth transition. CEO and Chairman Arun Menawat expressed confidence in Sobczyk's leadership and thanked Dewan for his contributions. The company continues to execute its growth strategy and drive adoption of its TULSA technology.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard